Rani Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results; Provides Corporate UpdateGlobeNewsWire • 03/22/23
Rani Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Business UpdatesGlobeNewsWire • 03/16/23
Celltrion and Rani Therapeutics Partner on Development of Oral Monoclonal Antibody TreatmentGlobeNewsWire • 01/09/23
Rani Therapeutics Receives Feedback from Pre-IND Meeting with FDA; Provides Pipeline UpdateGlobeNewsWire • 01/05/23
Rani Therapeutics Announces Repeat-Dose Topline Results from RT-102 Phase 1 StudyGlobeNewsWire • 12/06/22
Rani Therapeutics Holdings, Inc. (RANI) Reports Q3 Loss, Lags Revenue EstimatesZacks Investment Research • 11/10/22
Here's Why Rani Therapeutics Holdings, Inc. (RANI) Is a Great 'Buy the Bottom' Stock NowZacks Investment Research • 10/28/22
Rani Therapeutics Announces New RT-111 Development Program and Provides Corporate UpdateGlobeNewsWire • 10/24/22
Rani Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment ConferenceGlobeNewsWire • 09/06/22
Rani Therapeutics Announces Termination of Public Offering of Class A Common StockGlobeNewsWire • 08/12/22
Rani Therapeutics Holdings, Inc. (RANI) Reports Q2 Loss, Misses Revenue EstimatesZacks Investment Research • 08/10/22
Rani Therapeutics Reports Second Quarter 2022 Financial Results; Provides Corporate UpdateGlobeNewsWire • 08/10/22
Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of RT-102 in OsteoporosisGlobeNewsWire • 08/10/22
Rani Therapeutics Enters into $45 Million Loan Agreement to Support Ongoing RaniPill® Platform Advancement and Clinical Pipeline DevelopmentGlobeNewsWire • 08/08/22
Rani Therapeutics Reports First Quarter 2022 Financial Results; Provides Corporate UpdateGlobeNewsWire • 05/11/22
Rani Therapeutics to Present at the 21st Annual Needham Virtual Healthcare ConferenceGlobeNewsWire • 04/07/22
Rani Therapeutics Holdings, Inc. (RANI) Talat Imran on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/30/22
Rani Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results; Provides Corporate UpdateGlobeNewsWire • 03/29/22
Rani Therapeutics to Release Fourth Quarter and Full Year 2021 Financial Results on Tuesday, March 29, 2022GlobeNewsWire • 03/24/22
Rani Therapeutics Announces Initiation of Phase 1 Study of RT-102 Oral PTH for OsteoporosisGlobeNewsWire • 03/23/22
Rani Therapeutics Reports Third Quarter 2021 Financial Results, Provides Corporate UpdateGlobeNewsWire • 11/16/21